Amanta Healthcare Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 6 Aug 2026

Company page: Amanta Healthcare share price, financials & guidance record

Amanta Healthcare Limited reported a resilient Q1 FY27, achieving a 5% YoY revenue growth to INR69 crores and maintaining a 22% EBITDA margin. Despite delays in SteriPort Line 3 commissioning and cost pressures, the company is poised for significant growth with SteriPort Line 3 expected to be operational by August 2026 and the SVP facility by Q4 FY27. Strategic investments in capacity expansion, a new F&D pipeline, and a captive solar plant are set to drive future profitability and market presence.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 5.3%, net profit down 5.7% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	67	68	72	65	71 +6%	74 +10%	77 +7%	69 +5%
Expenses	53	53	53	50	56	59	62	54
EBITDA	14	15	19	15	15 +6%	15 +2%	15 −21%	15 −2%
Margin	21%	22%	26%	23%	21%	21%	19%	21%
Other income	0	1	0	1	-3	1	2	1
Interest	6	6	6	6	5	5	4	6
Depreciation	5	5	5	5	5	5	5	5
Profit before tax	3	6	8	5	2 −28%	6 +14%	8 −7%	4 −9%
Tax rate	29%	23%	27%	29%	47%	26%	27%	26%
Net profit	2	4	6	4	1 −46%	5 +8%	6 −7%	3 −6%
EPS	0.78	1.48	2.07	1.22	0.31	1.19	1.42	0.85

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls